283 related articles for article (PubMed ID: 22608946)
1. The occurrence and distribution of pharmaceutical compounds in the effluents of a major sewage treatment plant in Northern Taiwan and the receiving coastal waters.
Fang TH; Nan FH; Chin TS; Feng HM
Mar Pollut Bull; 2012 Jul; 64(7):1435-44. PubMed ID: 22608946
[TBL] [Abstract][Full Text] [Related]
2. Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment.
Verlicchi P; Al Aukidy M; Galletti A; Petrovic M; Barceló D
Sci Total Environ; 2012 Jul; 430():109-18. PubMed ID: 22634557
[TBL] [Abstract][Full Text] [Related]
3. Discharge of pharmaceutical products (PPs) through a conventional biological sewage treatment plant: MECs vs PECs?
Coetsier CM; Spinelli S; Lin L; Roig B; Touraud E
Environ Int; 2009 Jul; 35(5):787-92. PubMed ID: 19201471
[TBL] [Abstract][Full Text] [Related]
4. The occurrence of acidic drugs and caffeine in sewage effluents and receiving waters from three coastal watersheds in Atlantic Canada.
Comeau F; Surette C; Brun GL; Losier R
Sci Total Environ; 2008 Jun; 396(2-3):132-46. PubMed ID: 18377954
[TBL] [Abstract][Full Text] [Related]
5. Monitoring release of pharmaceutical compounds: occurrence and environmental risk assessment of two WWTP effluents and their receiving bodies in the Po Valley, Italy.
Al Aukidy M; Verlicchi P; Jelic A; Petrovic M; Barcelò D
Sci Total Environ; 2012 Nov; 438():15-25. PubMed ID: 22967493
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
Bendz D; Paxéus NA; Ginn TR; Loge FJ
J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
[TBL] [Abstract][Full Text] [Related]
7. Occurrence, distribution and environmental risk of pharmaceutically active compounds (PhACs) in coastal and ocean waters from the Gulf of Cadiz (SW Spain).
Biel-Maeso M; Baena-Nogueras RM; Corada-Fernández C; Lara-Martín PA
Sci Total Environ; 2018 Jan; 612():649-659. PubMed ID: 28866393
[TBL] [Abstract][Full Text] [Related]
8. Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea.
Choi K; Kim Y; Park J; Park CK; Kim M; Kim HS; Kim P
Sci Total Environ; 2008 Nov; 405(1-3):120-8. PubMed ID: 18684486
[TBL] [Abstract][Full Text] [Related]
9. Input of selected human pharmaceutical metabolites into the Norwegian aquatic environment.
Langford K; Thomas KV
J Environ Monit; 2011 Feb; 13(2):416-21. PubMed ID: 21152649
[TBL] [Abstract][Full Text] [Related]
10. Probabilistic environmental risk characterization of pharmaceuticals in sewage treatment plant discharges.
Christensen AM; Markussen B; Baun A; Halling-Sørensen B
Chemosphere; 2009 Oct; 77(3):351-8. PubMed ID: 19682723
[TBL] [Abstract][Full Text] [Related]
11. The occurrence of illicit and therapeutic pharmaceuticals in wastewater effluent and surface waters in Nebraska.
Bartelt-Hunt SL; Snow DD; Damon T; Shockley J; Hoagland K
Environ Pollut; 2009 Mar; 157(3):786-91. PubMed ID: 19110357
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical contamination in residential, industrial, and agricultural waste streams: risk to aqueous environments in Taiwan.
Lin AY; Yu TH; Lin CF
Chemosphere; 2008 Dec; 74(1):131-41. PubMed ID: 18829065
[TBL] [Abstract][Full Text] [Related]
13. Environmental fate of pharmaceutical compounds and antimicrobial-resistant bacteria in hospital effluents, and contributions to pollutant loads in the surface waters in Japan.
Azuma T; Otomo K; Kunitou M; Shimizu M; Hosomaru K; Mikata S; Ishida M; Hisamatsu K; Yunoki A; Mino Y; Hayashi T
Sci Total Environ; 2019 Mar; 657():476-484. PubMed ID: 30550911
[TBL] [Abstract][Full Text] [Related]
14. Determining the fraction of pharmaceutical residues in wastewater originating from a hospital.
Ort C; Lawrence MG; Reungoat J; Eaglesham G; Carter S; Keller J
Water Res; 2010 Jan; 44(2):605-15. PubMed ID: 19717180
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of anionic surfactants in treated sewage: risk assessment to aquatic environment.
Mungray AK; Kumar P
J Hazard Mater; 2008 Dec; 160(2-3):362-70. PubMed ID: 18430511
[TBL] [Abstract][Full Text] [Related]
16. Occurrence and removal of pharmaceutically active compounds in sewage treatment plants with different technologies.
Ying GG; Kookana RS; Kolpin DW
J Environ Monit; 2009 Aug; 11(8):1498-505. PubMed ID: 19657534
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceuticals and personal care products (PPCPs) in Australia's largest inland sewage treatment plant, and its contribution to a major Australian river during high and low flow.
Roberts J; Kumar A; Du J; Hepplewhite C; Ellis DJ; Christy AG; Beavis SG
Sci Total Environ; 2016 Jan; 541():1625-1637. PubMed ID: 26456435
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical compounds in the wastewater process stream in Northwest Ohio.
Spongberg AL; Witter JD
Sci Total Environ; 2008 Jul; 397(1-3):148-57. PubMed ID: 18396321
[TBL] [Abstract][Full Text] [Related]
19. Microbial degradation of pharmaceuticals in estuarine and coastal seawater.
Benotti MJ; Brownawell BJ
Environ Pollut; 2009 Mar; 157(3):994-1002. PubMed ID: 19038482
[TBL] [Abstract][Full Text] [Related]
20. Prediction of carbamazepine in sewage treatment plant effluents and its implications for control strategies of pharmaceutical aquatic contamination.
Zhang Y; Geissen SU
Chemosphere; 2010 Sep; 80(11):1345-52. PubMed ID: 20594577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
